Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Confirmatory Trial for Alleviating Fatigue in Multiple Sclerosis [NA]
This clinical trial update indicates a confirmatory trial is recruiting to evaluate therapies for alleviating fatigue in people with multipl…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Impact of TTNS on Bladder Symptoms Among People With MS, A RCT [NA]
An ongoing randomized trial is assessing whether transcutaneous tibial nerve stimulation (TTNS) improves bladder symptoms in people with mul…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Kesimpta® (Ofatumumab) in Swiss Multiple Sclerosis Patients - an Observational Study
An observational study evaluating Kesimpta (ofatumumab) in Swiss patients with multiple sclerosis has completed.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: How to Develop the Highest Possible Leading-edge Interdisciplinary Care Model for People With MS, That Will be Relevant to All Stakeholders and Declinable to Different Local Contexts With the Ultimate Goal of Ensuring the Highest Level of Quality of Care in MS.
A clinical trial protocol led by Assistance Publique - Hôpitaux de Paris to develop a leading-edge interdisciplinary care model for people w…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: VR-based Dexterity Training in MS [NA]
A clinical trial evaluating a virtual reality-based dexterity training program for people with Multiple Sclerosis. The study is currently no…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Turkish Version of the Neurogenic Bladder Symptom Score Short Form
Clinical trial update describing the Turkish version of the Neurogenic Bladder Symptom Score Short Form, sponsored by Gaziantep Islam Scienc…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases. [Phase 1]
Phase 1 clinical trial update assessing the safety and pharmacodynamics of QH103 cell injections in relapsed/refractory antibody-mediated ne…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Comparison of Frailty, Physical Fitness Parameters, and Irisin Levels Between Patients With Multiple Sclerosis and Healthy Volunteers
This clinical trial compares frailty, physical fitness parameters, and irisin levels between individuals with Multiple Sclerosis and healthy…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: My MS and My Menstrual Cycle
A University of Alberta clinical trial investigating the relationship between multiple sclerosis and the menstrual cycle has been suspended.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Multiple Sclerosis Falls Insight Track [NA]
This clinical trial update indicates a Multiple Sclerosis study is currently active but not recruiting participants.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Evaluate the Real-world Experience and Satisfaction Associated With Ofatumumab
This entry reports on a real-world study evaluating patient experience and satisfaction with ofatumumab for multiple sclerosis. The study is…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis [Phase 3]
This clinical trial update describes ongoing Phase 3 efficacy and safety studies of Frexalimab (SAR441344) in adults with relapsing forms of…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study on the Safety and Tolerability of Universal STAR-T Cell Therapy for Multiple Sclerosis. [Phase 1]
Phase 1 clinical trial updating safety and tolerability data for Universal STAR-T Cell Therapy in multiple sclerosis; the study is currently…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Impact of Exercise Training on Serum Glial Fibrillary Acidic Protein (GFAP), Brain Volumetry, and Functional Outcomes in Multiple Sclerosis [NA]
This ClinicalTrials.gov entry describes a NOT_YET_RECRUITING study at Firat University assessing the effects of exercise training on serum G…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Evaluation of the Effects of Laughter Yoga [NA]
A clinical trial evaluating the effects of laughter yoga in people with multiple sclerosis is currently recruiting at Firat University.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Walking Fatigability,Saptiotemporal Gait Parameters and Falling in MS Patients
A clinical trial investigating walking fatigability, spatiotemporal gait parameters, and falls in people with Multiple Sclerosis; the study …
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Safety and Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Multiple Sclerosis [Phase 1, Phase 2]
A Phase 1/2 clinical trial is assessing the safety and efficacy of Extracorporeal Photopheresis for Multiple Sclerosis, including Relapsing-…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Real World Outcomes of Intranasal MuSE Exosomes and Stem Cells in Neurological Regenerative Therapy
An update on an ongoing real-world study of intranasal MuSE exosomes and stem cells for neurological regenerative therapy, with enrollment b…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Effects of Stimulation Patterns of Deep Brain Stimulation [NA]
Clinical trial update on deep brain stimulation patterns for Parkinson disease and essential tremor, with potential relevance to multiple sc…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Relating Genetic and Environmental Risk Scores to Multiple Sclerosis Susceptibility
An update on a completed clinical study examining whether combined genetic and environmental risk scores influence susceptibility to multipl…
-
CLINICAL_TRIALS other · 2026-04-09Clinical Trial Update: Impact of Exercise Training on Serum Neurofilament Light Chain (NfL), Brain Volumetry, and Functional Outcomes in Multiple Sclerosis [NA]
Clinical trial update describing a study on how exercise training affects serum neurofilament light chain, brain volumetry, and functional o…
-
EMA approval · 2026-04-08EMA Authorised: Rebif (interferon beta-1a) — Merck Europe B.V.
EMA has authorised Rebif (interferon beta-1a) for use in the treatment of multiple sclerosis, with Merck Europe B.V. listed as the marketing…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of IMS001 in Subjects With Multiple Sclerosis [Phase 1]
Phase 1 clinical trial examining the safety, tolerability, and exploratory efficacy of IMS001 in adults with multiple sclerosis; the study i…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis [Phase 2]
A Phase 2 clinical trial update from Johns Hopkins evaluating glucagon-like peptide-1 receptor agonists for multiple sclerosis; the study is…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy [Phase 1]
Phase 1 clinical trial investigating the central nervous system uptake of anti-CD8+ T cell minibodies for multiple sclerosis and progressive…